Real Heart

Real Heart

Developing a heart pump (TAH) that mimics the body's natural circulation and that can be used as a transitional solution for patients waiting for a heart transplant. Learn more

Financials

Estimates*

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022
Revenues<1m<1m----<1m
% growth(14 %)465 %-----
EBITDA(<1m)(<1m)(<1m)(<1m)(<1m)(<1m)(1.3m)
% EBITDA margin(2794 %)(1267 %)----(143882 %)
Profit(<1m)(1.4m)(<1m)(<1m)(<1m)(1.0m)(1.3m)
% profit margin(2920 %)(1773 %)----(139902 %)
EV / revenue798.6x132.3x----8384.2x
EV / EBITDA-28.6x-10.4x----13.5x-5.8x

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
*
N/A

€1.5m

Angel

€2.5m

Grant
*

SEK200k

Grant
*

SEK850k

Grant

€1.3m

Early VC
Total FundingCAD8.1m

Recent News about Real Heart

Edit
More about Real Heart
Edit

Scandinavian Real Heart AB is engaged in developing an artificial heart.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.